, will test the HIVconsvX vaccine. University of Oxford professor Tomas Hanke says the vaccine is a "mosaic," capable of targeting a range of HIV-1 variants
While most HIV vaccine candidates work by attacking antibodies generated by B cells, Hanke explained that HIVconsvX uses the immune responses from T cells, a type of white blood cell that can kill virus-infected or cancerous cells, to target the most vulnerable regions of HIV. According to the university, the trial will assess the HIVconsvX vaccine's safety, tolerability, and immunogenicity.
Hanke said future trials will also look at combining the vaccine with other, antiviral drugs in an attempt to "establish control of the virus in the body.", 37.6 million people globally were living with HIV in 2020. Of these, 35.9 million were adults and 1.7 million were children under 15 years old.
They probably already have it for the ultra rich.
The comments section 😂 People don't read do they...
Since 70s, AIDS virusfrom Chimpanzee got into human being lives, millions died since then, and over45 years, there is no official cure for it! Since 2008 SARS, H1N1, EBOLA etc.viruses killed millions with no official cure! There many genetic disease whichtake human live!
Wow awesome 👌👏 it's only been 40 years.
The comments on this never fail to amuse me; this is fucking groundbreaking stuff but all people can do is wear tinfoil hats.
Lol they're like 'people will start asking how we have a covid vaxx so fast but not an hiv one all these years..and since rushed vaccines are totally cool with everyone, f it! Lets do it!'